Literature DB >> 25003905

[Epidemiology and costs of asthma in Germany - a systematic literature review].

I Aumann1, A Prenzler1, T Welte2, A Gillissen3.   

Abstract

BACKGROUND: The aim of this study was to identify the prevalence and incidence as well as the health care costs of asthma specifically in the German setting.
METHODS: Two systematic literature searches were conducted in PubMed in December 2012 (updated in March 2014). All publications in German and English were included.
RESULTS: After review of title, abstracts and full publications, 17 relevant studies included information on the prevalence and incidence of asthma. The 12-month prevalence for adults ranges between 4.6 % and 6.34 % (children: 3.8 % - 11.8 %). At younger ages, asthma is more prevalent in boys. In adulthood, more women are affected. We identified seven cost-of-illness studies. The direct costs range between € 690.4 m and 1.36 bn. The reported health care costs depend on the perspective, the severity of disease and the database, so that a comparison of results is difficult.
CONCLUSION: All in all, this review underlines the epidemiological and health economic importance of asthma in Germany. Several studies on the prevalence of asthma are available, but there is little information on the current incidence of this disease. Further research is necessary for obtaining a comprehensive picture of the current health care costs. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2014        PMID: 25003905     DOI: 10.1055/s-0034-1377225

Source DB:  PubMed          Journal:  Pneumologie        ISSN: 0934-8387


  10 in total

1.  Healthcare costs and resource utilization of asthma in Germany: a claims data analysis.

Authors:  Christian Jacob; Benno Bechtel; Susanne Engel; Peter Kardos; Roland Linder; Sebastian Braun; Wolfgang Greiner
Journal:  Eur J Health Econ       Date:  2015-02-26

Review 2.  Asthma costs and social impact.

Authors:  Carlos Nunes; Ana Margarida Pereira; Mário Morais-Almeida
Journal:  Asthma Res Pract       Date:  2017-01-06

3.  Prevalence and Geographic Distribution Pattern of Asthma in Tehran by ECRHS.

Authors:  Hooman Sharifi; Mostafa Ghanei; Makan Sadr; Habib Emami; Atefeh Fakharian; Zahra Hessami; Mahshid Aryanpur; Hamidreza Jamaati; Mohammad Reza Masjedi
Journal:  Tanaffos       Date:  2016

4.  Estimates of costs for modelling return on investment from smoking cessation interventions.

Authors:  Marta Trapero-Bertran; Reiner Leidl; Celia Muñoz; Puttarin Kulchaitanaroaj; Kathryn Coyle; Maximilian Präger; Judit Józwiak-Hagymásy; Kei Long Cheung; Mickael Hiligsmann; Subhash Pokhrel
Journal:  Addiction       Date:  2018-03-13       Impact factor: 6.526

5.  What are the perceived influences on asthma self-management at the workplace? A qualitative study.

Authors:  Katherina Heinrichs; Patricia Vu-Eickmann; Stefan Hummel; Jalal Gholami; Adrian Loerbroks
Journal:  BMJ Open       Date:  2018-08-29       Impact factor: 2.692

6.  The Differential Expression Profiles of miRNA-let 7a, 7b, and 7c in Bronchoalveolar Lavage Fluid From Infants With Asthma and Airway Foreign Bodies.

Authors:  Hang-Hu Zhang; Cai-Xue Li; Lan-Fang Tang
Journal:  J Evid Based Integr Med       Date:  2019 Jan-Dec

7.  Prevalence of oral corticosteroid use in the German severe asthma population.

Authors:  Christian Taube; Peter Bramlage; Annette Hofer; Dörte Anderson
Journal:  ERJ Open Res       Date:  2019-10-30

8.  Determinants of patients' needs in asthma treatment: a cross-sectional study.

Authors:  Adrian Loerbroks; Aziz Sheikh; Verena Leucht; Christian J Apfelbacher; Andrea Icks; Peter Angerer
Journal:  NPJ Prim Care Respir Med       Date:  2016-08-11       Impact factor: 2.871

9.  High probability of comorbidities in bronchial asthma in Germany.

Authors:  S Heck; S Al-Shobash; D Rapp; D D Le; A Omlor; A Bekhit; M Flaig; B Al-Kadah; W Herian; R Bals; S Wagenpfeil; Q T Dinh
Journal:  NPJ Prim Care Respir Med       Date:  2017-04-21       Impact factor: 2.871

10.  Trends and regional distribution of outpatient claims for asthma, 2009-2016, Germany.

Authors:  Manas K Akmatov; Jakob Holstiege; Annika Steffen; Jörg Bätzing
Journal:  Bull World Health Organ       Date:  2019-11-01       Impact factor: 9.408

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.